Dynamic effects of smoking cessation on disease incidence, mortality and quality of life: The role of time since cessation

Cost Effectiveness and Resource Allocation : C/E
R T HoogenveenT L Feenstra

Abstract

To support health policy makers in setting priorities, quantifying the potential effects of tobacco control on the burden of disease is useful. However, smoking is related to a variety of diseases and the dynamic effects of smoking cessation on the incidence of these diseases differ. Furthermore, many people who quit smoking relapse, most of them within a relatively short period. In this paper, a method is presented for calculating the effects of smoking cessation interventions on disease incidence that allows to deal with relapse and the effect of time since quitting. A simulation model is described that links smoking to the incidence of 14 smoking related diseases. To demonstrate the model, health effects are estimated of two interventions in which part of current smokers in the Netherlands quits smoking.To illustrate the advantages of the model its results are compared with those of two simpler versions of the model. In one version we assumed no relapse after quitting and equal incidence rates for all former smokers. In the second version, incidence rates depend on time since cessation, but we assumed still no relapse after quitting. Not taking into account time since smoking cessation on disease incidence rates results in b...Continue Reading

References

Aug 1, 1994·American Journal of Public Health·Y Ben-ShlomoM G Marmot
Oct 9, 1997·The New England Journal of Medicine·J J BarendregtP J van der Maas
Aug 7, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·I MulderH B Bueno-de-Mesquita
Jan 6, 2001·Journal of Health Politics, Policy and Law·D T Levy, K B Friend
Feb 24, 2001·MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports
Aug 18, 2001·Japanese Journal of Cancer Research : Gann·K WakaiUNKNOWN JACC Study Group. Japan Collaborative Cohort Study
Aug 25, 2001·American Journal of Respiratory and Critical Care Medicine·T L FeenstraM P Rutten-van Mölken
Apr 4, 2003·International Journal of Cancer. Journal International Du Cancer·Masahiko AndoUNKNOWN JACC Study Group
Aug 3, 2004·American Journal of Epidemiology·Katherine M FlegalDavid F Williamson
Jul 9, 2005·Stroke; a Journal of Cerebral Circulation·Jeroen N StruijsGeertrudis A M van den Bos
Nov 7, 2006·Population Health Metrics·Pieter H M van BaalHendriek C Boshuizen
Jan 24, 2007·Cost Effectiveness and Resource Allocation : C/E·Susan F Hurley, Jane P Matthews

❮ Previous
Next ❯

Citations

Aug 27, 2009·European Journal of Public Health·Cindy M Gielkens-SijstermansOnno C van Schayck
Sep 25, 2012·Health Policy and Planning·Akram Khayatzadeh-MahaniGillian Harvey
Sep 26, 2012·Cost Effectiveness and Resource Allocation : C/E·Eelco Ab OverPieter Hm van Baal
May 14, 2010·Cost Effectiveness and Resource Allocation : C/E·Anura K Amarasinghe
Sep 17, 2010·Cost Effectiveness and Resource Allocation : C/E·Louisa G GordonPaul M Brown
Oct 7, 2011·Cost Effectiveness and Resource Allocation : C/E·Talitha L FeenstraCaroline A Baan
Dec 2, 2008·BMC Medicine·Matthijs van den BergRudolf T Hoogenveen
Jan 7, 2014·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Eelco A B OverBoukje M van Gelder
Mar 1, 2014·International Journal of Environmental Research and Public Health·Laura CarrozziGiovanni Viegi
Nov 26, 2015·Applied Health Economics and Health Policy·Ataru IgarashiJörgen Moller
Feb 2, 2010·American Journal of Preventive Medicine·Stefan K LhachimiJohan P Mackenbach
Jan 7, 2011·Health Economics·Pieter H M van BaalWerner B F Brouwer
Jun 20, 2013·Current Medical Research and Opinion·Xiaomei PengDiego Novick
Dec 14, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Martine HoogendoornTalitha L Feenstra
Aug 13, 2013·Regulatory Toxicology and Pharmacology : RTP·Annette M Bachand, Sandra I Sulsky
Oct 25, 2014·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Maria GheorghePieter H M van Baal
Feb 23, 2019·Epidemiology·Frederieke S Petrović-van der DeenTony Blakely
May 8, 2018·PharmacoEconomics·Becky PenningtonMatthew Taylor
Oct 11, 2020·International Journal of Epidemiology·Tony BlakelyAbraham Flaxman

❮ Previous
Next ❯

Software Mentioned

RIVM
SimSmoke

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.